Therapeutic and cosmeceutical potential of ethosomes: An overview
- PMID:22247858
- PMCID: PMC3255417
- DOI: 10.4103/0110-5558.72415
Therapeutic and cosmeceutical potential of ethosomes: An overview
Abstract
The main disadvantage of transdermal drug delivery is the poor penetration of most compounds into the human skin. The main barrier of the skin is located within its uppermost layer, the stratum corneum (SC). Several approaches have been developed to weaken this skin barrier. One of the approaches for increasing the skin penetration of drugs and many cosmetic chemicals is the use of vesicular systems, such as, liposomes and ethosomes. Ethosomes are phospholipid-based elastic nanovesicles containing a high content of ethanol (20-45%). Ethanol is known as an efficient permeation enhancer and has been added in the vesicular systems to prepare elastic nanovesicles. It can interact with the polar head group region of the lipid molecules, resulting in the reduction of the melting point of the stratum corneum lipid, thereby increasing lipid fluidity and cell membrane permeability. The high flexibility of vesicular membranes from the added ethanol permits the elastic vesicles to squeeze themselves through the pores, which are much smaller than their diameters. Ethosomal systems are much more efficient in delivering substances to the skin in the terms of quantity and depth, than either conventional liposomes or hydroalcoholic solutions. The scope of this small review is to introduce the novel concept of ethosomes and to describe some approaches and mechanisms of stimulating topical and transdermal products with ethosomes.
Keywords: Ethosomes; Percutaneous absorption; liposomes; novel drug delivery; penetration enhancer.
Conflict of interest statement
Figures
Similar articles
- Phospholipid Vesicles for Dermal/Transdermal and Nasal Administration of Active Molecules: The Effect of Surfactants and Alcohols on the Fluidity of Their Lipid Bilayers and Penetration Enhancement Properties.Natsheh H, Touitou E.Natsheh H, et al.Molecules. 2020 Jun 27;25(13):2959. doi: 10.3390/molecules25132959.Molecules. 2020.PMID:32605117Free PMC article.Review.
- Mechanism of transdermal permeation promotion of lipophilic drugs by ethosomes.Yang L, Wu L, Wu D, Shi D, Wang T, Zhu X.Yang L, et al.Int J Nanomedicine. 2017 Apr 26;12:3357-3364. doi: 10.2147/IJN.S134708. eCollection 2017.Int J Nanomedicine. 2017.PMID:28490875Free PMC article.
- Transdermal applications of ethosomes - a detailed review.Nainwal N, Jawla S, Singh R, Saharan VA.Nainwal N, et al.J Liposome Res. 2019 Jun;29(2):103-113. doi: 10.1080/08982104.2018.1517160. Epub 2018 Oct 12.J Liposome Res. 2019.PMID:30156120Review.
- Ethosomes as dermal/transdermal drug delivery systems: applications, preparation and characterization.Jafari A, Daneshamouz S, Ghasemiyeh P, Mohammadi-Samani S.Jafari A, et al.J Liposome Res. 2023 Mar;33(1):34-52. doi: 10.1080/08982104.2022.2085742. Epub 2022 Jun 13.J Liposome Res. 2023.PMID:35695714Review.
- Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties.Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M.Touitou E, et al.J Control Release. 2000 Apr 3;65(3):403-18. doi: 10.1016/s0168-3659(99)00222-9.J Control Release. 2000.PMID:10699298
Cited by
- Ethosomal Gel Formulation of Alpha Phellandrene for the Transdermal Delivery in Gout.Valsalan Soba S, Babu M, Panonnummal R.Valsalan Soba S, et al.Adv Pharm Bull. 2021 Jan;11(1):137-149. doi: 10.34172/apb.2021.015. Epub 2020 Nov 7.Adv Pharm Bull. 2021.PMID:33747861Free PMC article.
- Development and Evaluation of Ethosomes Loaded withZingiber zerumbet Linn Rhizome Extract for Antifungal Skin Infection in Deep Layer Skin.Huanbutta K, Rattanachitthawat N, Luangpraditkun K, Sriamornsak P, Puri V, Singh I, Sangnim T.Huanbutta K, et al.Pharmaceutics. 2022 Dec 9;14(12):2765. doi: 10.3390/pharmaceutics14122765.Pharmaceutics. 2022.PMID:36559259Free PMC article.
- Current advances in nanodrug delivery systems for malaria prevention and treatment.Kekani LN, Witika BA.Kekani LN, et al.Discov Nano. 2023 Apr 20;18(1):66. doi: 10.1186/s11671-023-03849-x.Discov Nano. 2023.PMID:37382765Free PMC article.Review.
- Quality by Design for Development, Optimization and Characterization of Brucine Ethosomal Gel for Skin Cancer Delivery.Ismail TA, Shehata TM, Mohamed DI, Elsewedy HS, Soliman WE.Ismail TA, et al.Molecules. 2021 Jun 7;26(11):3454. doi: 10.3390/molecules26113454.Molecules. 2021.PMID:34200144Free PMC article.
- Plumbagin-Loaded Glycerosome Gel as Topical Delivery System for Skin Cancer Therapy.Md S, Alhakamy NA, Aldawsari HM, Husain M, Khan N, Alfaleh MA, Asfour HZ, Riadi Y, Bilgrami AL, Akhter MH.Md S, et al.Polymers (Basel). 2021 Mar 17;13(6):923. doi: 10.3390/polym13060923.Polymers (Basel). 2021.PMID:33802819Free PMC article.
References
- Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci. 2001;14:101–14. - PubMed
- Hadgraft J. Passive enhancement strategies in topical and transdermal drug delivery. Int J Pharm. 1999;184:1–6. - PubMed
- Thong HY, Zhai H, Maibach HI. Percutaneous enhancers: An overview. J Skin Pharmacol Physiol. 2007;2:1–12. - PubMed
- Shim J, Kang HS, Park WS, Han SH. Transdermal delivery of minoxidil with ethanolic liposomes. J Cont Rel. 2003;97:477–84. - PubMed
- Essa AE, Bonner MC, Barry BW. Electroporation and ultradeformable liposomes; Human skin barrier repair by phospholipids. J Cont Rel. 2003;92:163–72. - PubMed
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources